• Ran Lactylation Links Lactate to Astrocyte Polarization

  2026-08-19

  The reference study identifies Ran lactylation at lysine 123 as a non-histone mechanism connecting lactate accumulation with STAT3 nuclear transport and A2-like astrocyte polarization after oxygen-glucose deprivation/reoxygenation. Its combination of metabolic manipulation, lactylome analysis, genetic perturbation, and spinal cord injury models provides a framework for testing SIRT1-dependent metabolic-epigenetic signaling in CNS repair.

• Dual SMAD–Wnt Inhibition for iPSC-Derived RGCs

  2026-08-19

  Chavali and colleagues developed a chemically defined, non-genetic strategy that combines dual SMAD and canonical Wnt inhibition to generate retinal ganglion cells from induced pluripotent stem cells with improved efficiency and reproducibility. The approach produced cultures exceeding 80% RGC purity and enabled magnetic enrichment to nearly 95%, providing a practical foundation for glaucoma modeling and mechanistic studies.

• Carvedilol Phosphate: A Mechanistic IRI Tool

  2026-08-18

  Carvedilol Phosphate can serve as a controlled non-selective beta blocker perturbation in cardiovascular and hepatic ischemia–reperfusion studies. This article connects compound handling with the Arrb2–6-ketoLCA hepatocyte–macrophage axis while distinguishing established evidence from testable experimental hypotheses.

• LG 101506: Practical RXR Modulator Workflows

  2026-08-18

  LG 101506 is a research-ready RXR modulator for connecting nuclear receptor activity with transcriptional, differentiation, and metabolism-focused assays. This workflow-centered guide shows how to prepare, dose, validate, and troubleshoot the compound while using TNBC checkpoint biology as a disciplined translational framework rather than an unsupported efficacy claim.

• Hoechst 33342/PI Kit for Cell Death

  2026-08-17

  Learn how the Hoechst 33342/PI Double Staining Kit converts nuclear morphology and membrane integrity into an interpretable cell-death profile. This article connects Hoechst 33342 propidium iodide staining with mechanistic research on esculin-treated renal cell carcinoma while clarifying assay limitations and complementary validation methods.

• Nintedanib in ATRX-Deficient Glioma Research

  2026-08-17

  Nintedanib (BIBF 1120) enables a practical multi-target workflow for studying VEGFR, FGFR, and PDGFR signaling in cancer and fibrosis models. Its strongest differentiation is the ability to connect angiogenesis inhibition with ATRX-status stratification and temozolomide combination testing.

• Superoxide Dismutase Activity Assay Kit Guide

  2026-08-16

  The Superoxide Dismutase Activity Assay Kit (SKU K2035) provides a colorimetric way to quantify SOD activity in biological fluids through WST-1 reduction driven by xanthine oxidase-generated superoxide. It is suitable for research workflows such as oxidative stress studies, but it should not be used as a diagnostic test or treated as a direct measurement of total reactive oxygen species.

• Pickering Multiple Emulsions for Cancer mRNA Vaccines

  2026-08-15

  Yufei Xia’s 2024 Gunma University dissertation examines water-in-oil-in-water Pickering multiple emulsions as delivery and adjuvant platforms for protein and mRNA cancer vaccines. Its central finding is that calcium phosphate-stabilized emulsions can protect mRNA, support dendritic-cell transfection, avoid the liver-dominant expression pattern associated with the tested LNP comparator, and improve antitumor immune responses in mouse models.

• GSTA1, Glutathione Depletion, and α-Amanitin Toxicity

  2026-08-14

  The reference study identifies GSTA1 as an unexpected driver of α-amanitin-induced liver injury rather than simply a protective antioxidant enzyme. By combining mouse toxicology, multi-omics, protein-interaction assays, and genetic perturbation, the authors link NRF2-dependent GSTA1 upregulation to glutathione depletion, reactive oxygen species accumulation, and hepatocyte damage.

• Metal-Ion-Chelating L-Phe Nanostructures Enhance ICB

  2026-08-14

  A Nature Nanotechnology study developed metal-ion-chelating L-phenylalanine nanostructures that reprogram dendritic-cell ion signaling and remodel immunosuppressive tumour microenvironments. When paired with short-term starvation, these materials improved dendritic-cell maturation, tumour-specific cytotoxic T-cell responses, and sensitivity of breast and colorectal tumour models to immune checkpoint blockade.

• Recombinant Annexin V for Apoptosis Detection

  2026-08-13

  Brumatti, Sheridan, and Martin established a practical workflow for expressing, purifying, and fluorescein-labeling recombinant annexin V as a probe for phosphatidylserine externalization. The method supports rapid flow-cytometric and microscopic detection of apoptotic membrane changes while clarifying why calcium dependence, membrane integrity, and assay interpretation must be considered together.

• Nystatin (Fungicidin) Research Workflows

  2026-08-13

  Build reproducible Candida assays with Nystatin (Fungicidin), from DMSO stock preparation and MIC testing to adhesion, biofilm, and combination studies. A 2024 reference study also shows how ergosterol modulation can sharpen polyene experiments, while formulation and assay controls help distinguish true antifungal activity from solubility artifacts.

• Macrophage Mertk in Angiotensin II Heart Failure

  2026-08-12

  The reference study identifies macrophage Mertk as an unexpected driver of pressure overload-induced cardiac hypertrophy and heart failure. Its mechanistic model links efferocytosis of apoptotic cardiomyocytes to mitochondrial double-stranded RNA, macrophage TLR3 activation, type I interferon signaling, and impaired cardiomyocyte mitophagy.

• (-)-Blebbistatin Workflow for Myosin II Studies

  2026-08-12

  Use (-)-Blebbistatin as a reversible, cell-permeable probe to separate actomyosin-dependent mechanics from electrical or morphological signals. This workflow connects cytoskeletal assays with panoramic cardiac opto-electrical mapping while emphasizing dose finding, vehicle controls, washout, and motion-artifact troubleshooting.

• Resveratrol: A Mechanism-First Neuroprotection Guide

  2026-08-11

  Resveratrol is a widely used SIRT1 activator with potential to connect mitochondrial biogenesis, oxidative-stress control, and apoptosis assays. This guide translates the 2024 N2a-cell evidence into a mechanism-first framework for designing and interpreting neuroprotection experiments.

16219 records 1/1082 page Next 12345 下5页 Last page